HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protein kinase clk/STY is differentially regulated during erythroleukemia cell differentiation: a bias toward the skipped splice variant characterizes postcommitment stages.

Abstract
Clk/STY is a LAMMER protein kinase capable to phosphorylate serine/arginine-rich (SR) proteins that modulate pre-mRNA splicing. Clk/STY alternative splicing generates transcripts encoding a full-length kinase and a truncated catalytically inactive protein. Here we showed that clk/STY, as well as other members of the family (e.g. clk2, clk3 and clk4), are up-regulated during HMBA-induced erythroleukemia cell differentiation. mRNAs coding for the full-length and the truncated forms were responsible for the overall increased expression. In clk/STY, however, a switch was observed for the ratio of the two alternative spliced products. In undifferentiated cells the full-length transcript was more abundant whereas the transcript encoding for the truncated form predominated at latter stages of differentiation. Surprisingly, overexpression of clk/STY did not alter the splicing switch upon differentiation in MEL cells. These results suggest that clk/STY might contribute to control erythroid differentiation by a mechanism that implicates a balance between these two isoforms.
AuthorsAna García-Sacristán, María J Fernández-Nestosa, Pablo Hernández, Jorge B Schvartzman, Dora B Krimer
JournalCell research (Cell Res) Vol. 15 Issue 7 Pg. 495-503 (Jul 2005) ISSN: 1001-0602 [Print] England
PMID16045812 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetamides
  • Isoenzymes
  • Clk dual-specificity kinases
  • Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • hexamethylene bisacetamide
Topics
  • Acetamides (pharmacology)
  • Alternative Splicing (drug effects)
  • Animals
  • Cell Differentiation (drug effects, physiology)
  • Cell Line, Tumor
  • Exons
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Isoenzymes (drug effects, genetics, metabolism)
  • Leukemia, Erythroblastic, Acute (drug therapy, enzymology, genetics)
  • Mice
  • Multigene Family
  • Protein Serine-Threonine Kinases (drug effects, genetics, metabolism)
  • Protein-Tyrosine Kinases (drug effects, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: